BHI Stem Cells

BHI Therapeutic Sciences is a clinical-stage biotechnology company specializing in the development and commercialization of regenerative medicine and stem cell therapies. The company focuses on utilizing umbilical cord-derived mesenchymal stem cells (UC-MSCs) to treat a variety of conditions, including neurological disorders, orthopedic injuries, and autoimmune diseases. BHI Therapeutic Sciences operates international clinical research facilities and is actively involved in several FDA-cleared clinical trials for indications such as stroke and spinal cord injury. Their mission is to provide advanced cellular treatments that improve patient quality of life through rigorous scientific research and clinical application. The company maintains a global presence with research and treatment centers in the United States, Slovakia, and Jamaica.